TherapeuticsMD Company Insiders

TherapeuticsMD Management Team Effectiveness

The company has return on total asset (ROA) of (0.0273) % which means that it has lost $0.0273 on every $100 spent on assets. This is way below average. TherapeuticsMD's management efficiency ratios could be used to measure how well TherapeuticsMD manages its routine affairs as well as how well it operates its assets and liabilities. The market capitalization of TherapeuticsMD is $25 Million. About 69.73 % of TherapeuticsMD outstanding shares are held by general public with 1.54 (%) owned by insiders and only 28.73 % by institutional holders. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company. Some institutional investors establish a significant position in stocks such as TherapeuticsMD in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of TherapeuticsMD, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

TherapeuticsMD Workforce Comparison

The company has Profit Margin (PM) of 0.11 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (0.38) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.38.

TherapeuticsMD Insider Trading

TherapeuticsMD Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as TherapeuticsMD often depends on how effective the management is. TherapeuticsMD management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of TherapeuticsMD management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the TherapeuticsMD management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of TherapeuticsMD's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, TherapeuticsMD's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of TherapeuticsMD's management manipulating its earnings.

When running TherapeuticsMD's price analysis, check to measure TherapeuticsMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TherapeuticsMD is operating at the current time. Most of TherapeuticsMD's value examination focuses on studying past and present price action to predict the probability of TherapeuticsMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TherapeuticsMD's price. Additionally, you may evaluate how the addition of TherapeuticsMD to your portfolios can decrease your overall portfolio volatility.